ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Arizona » Rheumatology

Top Rheumatology Prescribers in Arizona

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
RAVI BHALLA M.D.

Rheumatology

21,107

$2.08M

1811
1208 are 65+

11%
patients receiving schedule two controlled substances

Avg: 9%

15%
patients receiving schedule three controlled substances

Avg: 11%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 23%

$98
Average prescription price

Avg: $161

STUART POSNER MD

Rheumatology

9,744

$1.49M

537
219 are 65+

50%
patients receiving schedule two controlled substances

Avg: 9%

23%
patients receiving schedule three controlled substances

Avg: 11%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 23%

$153
Average prescription price

Avg: $161

ULKER TOK M.D.

Rheumatology

7,660

$1.5M

704
425 are 65+

5%
patients receiving schedule two controlled substances

Avg: 9%

9%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 23%

$196
Average prescription price

Avg: $161

JOY SCHECHTMAN DO

Rheumatology

7,424

$1.64M

758
559 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

3%
patients receiving schedule three controlled substances

Avg: 11%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 23%

$221
Average prescription price

Avg: $161

VIJAYABHANU MAHADEVAN M.D.

Rheumatology

7,365

$1.05M

884
621 are 65+

8%
patients receiving schedule two controlled substances

Avg: 9%

12%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 23%

$142
Average prescription price

Avg: $161

JOSEPH NOLAN MD

Rheumatology

5,764

$796K

432
190 are 65+

24%
patients receiving schedule two controlled substances

Avg: 9%

22%
patients receiving schedule three controlled substances

Avg: 11%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

13%
prescriptions for brand name drugs

Avg: 23%

$138
Average prescription price

Avg: $161

NEHAD SOLOMAN M.D.

Rheumatology

5,433

$1.02M

617
404 are 65+

11%
patients receiving schedule two controlled substances

Avg: 9%

10%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 23%

$187
Average prescription price

Avg: $161

BURHAN CHINIKHANWALA MD

Rheumatology

5,123

$665K

643
433 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

19%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 23%

$130
Average prescription price

Avg: $161

RALPH BENNETT MD

Rheumatology

4,734

$473K

669
505 are 65+

13%
patients receiving schedule two controlled substances

Avg: 9%

17%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 23%

$100
Average prescription price

Avg: $161

GARY SILVERMAN D.O.

Rheumatology

4,277

$485K

269
150 are 65+

19%
patients receiving schedule two controlled substances

Avg: 9%

17%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 23%

$113
Average prescription price

Avg: $161

MICHAEL MARICIC MD

Rheumatology

4,209

$737K

529
419 are 65+

11%
patients receiving schedule two controlled substances

Avg: 9%

16%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 23%

$175
Average prescription price

Avg: $161

MICHAEL FAIRFAX D.O.

Rheumatology

3,989

$1.15M

638
358 are 65+

23%
patients receiving schedule two controlled substances

Avg: 9%

17%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 23%

$288
Average prescription price

Avg: $161

ALAN MALLACE MD

Rheumatology

3,896

$561K

659
495 are 65+

11%
patients receiving schedule two controlled substances

Avg: 9%

20%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 23%

$144
Average prescription price

Avg: $161

BRIDGET WALSH DO

Rheumatology

3,829

$580K

421
300 are 65+

10%
patients receiving schedule two controlled substances

Avg: 9%

16%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 23%

$151
Average prescription price

Avg: $161

AUGUSTO POSADAS MD

Rheumatology

3,596

$595K

405
280 are 65+

13%
patients receiving schedule two controlled substances

Avg: 9%

8%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 23%

$166
Average prescription price

Avg: $161

KENNETH LAWLOR DO

Rheumatology

3,263

$389K

402
272 are 65+

3%
patients receiving schedule two controlled substances

Avg: 9%

8%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 23%

$119
Average prescription price

Avg: $161

SHANNON HOWE MD

Rheumatology

3,051

$639K

304
241 are 65+

6%
patients receiving schedule two controlled substances

Avg: 9%

10%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 23%

$209
Average prescription price

Avg: $161

BENJAMIN K. HARRIS HARRIS M.D.

Rheumatology

2,960

$299K

297
252 are 65+

5%
patients receiving schedule two controlled substances

Avg: 9%

18%
patients receiving schedule three controlled substances

Avg: 11%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 23%

$101
Average prescription price

Avg: $161

AREENA SWARUP MD

Rheumatology

2,850

$470K

443
346 are 65+

9%
patients receiving schedule two controlled substances

Avg: 9%

20%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 23%

$165
Average prescription price

Avg: $161

ERIC PETERS MD

Rheumatology

2,779

$395K

495
415 are 65+

5%
patients receiving schedule two controlled substances

Avg: 9%

4%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 23%

$142
Average prescription price

Avg: $161

JEFFREY LOOMER MD

Rheumatology

2,742

$236K

185
142 are 65+

23%
patients receiving schedule two controlled substances

Avg: 9%

16%
patients receiving schedule three controlled substances

Avg: 11%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

13%
prescriptions for brand name drugs

Avg: 23%

$86
Average prescription price

Avg: $161

WARREN RIZZO MD

Rheumatology

2,741

$506K

314
246 are 65+

8%
patients receiving schedule two controlled substances

Avg: 9%

8%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 23%

$185
Average prescription price

Avg: $161

PAUL HOWARD M.D.

Rheumatology

2,671

$635K

398
347 are 65+

6%
patients receiving schedule two controlled substances

Avg: 9%

11%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 23%

$238
Average prescription price

Avg: $161

DEBORAH POWER DO

Rheumatology

2,632

$606K

182
91 are 65+

18%
patients receiving schedule two controlled substances

Avg: 9%

19%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 23%

$230
Average prescription price

Avg: $161

ALEIX BAZZI MD

Rheumatology

2,593

$460K

324
273 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 11%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 23%

$177
Average prescription price

Avg: $161

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank